Intervacc AB IVACC
Dividend Summary
There have not been any declared dividends recently.
| Summary | Previous dividend | Next dividend |
|---|---|---|
| Status | – | – |
| Type | – | – |
| Per share | – | – |
| Declaration date | – | – |
| Ex-div date | – | – |
| Pay date | – | – |
Enter the number of Intervacc AB shares you hold and we'll calculate your dividend payments:
Sign up for Intervacc AB and we'll email you the dividend information when they declare.
Add Intervacc AB to receive free notifications when they declare their dividends.
Your account is set up to receive Intervacc AB notifications.
| Status | Type | Decl. date | Ex-div date | Pay date | Decl. Currency | Forecast amount | Decl. amount | Accuracy |
|---|---|---|---|---|---|---|---|---|
| There are no Intervacc AB dividends. | ||||||||
| Year | Amount | Change |
|---|---|---|
| 2006 | 0.0öre | — |
| 2007 | 0.0öre | 0% |
| 2008 | 0.0öre | 0% |
| 2009 | 0.0öre | 0% |
| 2010 | 0.0öre | 0% |
| 2011 | 0.0öre | 0% |
| 2012 | 0.0öre | 0% |
| 2013 | 0.0öre | 0% |
| 2014 | 0.0öre | 0% |
| 2015 | 0.0öre | 0% |
| 2016 | 0.0öre | 0% |
| 2017 | 0.0öre | 0% |
| 2018 | 0.0öre | 0% |
| 2019 | 0.0öre | 0% |
| 2020 | 0.0öre | 0% |
| 2021 | 0.0öre | 0% |
| 2022 | 0.0öre | 0% |
| 2023 | 0.0öre | 0% |
| 2024 | Sign Up Required | |
Intervacc AB Optimized Dividend Chart
- Dividend Yield Today
- 0.0%
- Optimized Yield
- Sign Up Required
- 52 Week High
- 0.0% on 22 November 2023
- 52 Week Low
- 0.0% on 22 November 2023
- Next Ex-Div-Date Countdown
- Sign Up Required
About Intervacc AB
Intervacc AB is a Sweden-based biotechnology company. It develops vaccines based on recombinant proteins for animal health care. The Company’s candidate vaccine against strangles Strangvac consists of soluble recombinant proteins and devoids any living infectious agent. The Company operates through two subsidiaries: Nord Vacc Lakemedel AB and Mybac-Vettech AB. Nord Vacc Lakemedel AB markets and distributes veterinary vaccines, pharmaceuticals and vitamins on European market. It offers assortment of fur animal vaccines, the Febrivac range, as well as swine vaccines for Swedish and Danish markets. Mybac-Vettech AB is a technology platform that focuses on diagnostics in the Swedish animal health market and offers bacteriological and mycological analyses.
- Sector
- Pharmaceuticals & Biotechnology
- Country
- Sweden
- Share Price
- kr2.54 (yesterday's closing price)
- Shares in Issue
- 76 million
- Market Cap
- kr192mn
- 0
- Market Indices
- none
